These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 38812028)

  • 1. Cholinesterase inhibitors and memantine are associated with a reduced mortality in nursing home residents with dementia: a longitudinal observational study.
    Havreng-Théry C; Oquendo B; Zolnowski-Kolp V; Krolak-Salmon P; Bertin-Hugault F; Lafuente-Lafuente C; Belmin J
    Alzheimers Res Ther; 2024 May; 16(1):117. PubMed ID: 38812028
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cholinesterase inhibitor and memantine use in newly admitted nursing home residents with dementia.
    Parsons C; Briesacher BA; Givens JL; Chen Y; Tjia J
    J Am Geriatr Soc; 2011 Jul; 59(7):1253-9. PubMed ID: 21668913
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of Antidementia Therapies With Time to Skilled Nursing Facility Admission and Cardiovascular Events Among Elderly Adults With Alzheimer Disease.
    San-Juan-Rodriguez A; Zhang Y; He M; Hernandez I
    JAMA Netw Open; 2019 Mar; 2(3):e190213. PubMed ID: 30821828
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors Associated With Deprescribing Acetylcholinesterase Inhibitors in Older Nursing Home Residents With Severe Dementia.
    Niznik JD; Zhao X; He M; Aspinall SL; Hanlon JT; Nace D; Thorpe JM; Thorpe CT
    J Am Geriatr Soc; 2019 Sep; 67(9):1871-1879. PubMed ID: 31162642
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-utility analysis of memantine extended release added to cholinesterase inhibitors compared to cholinesterase inhibitor monotherapy for the treatment of moderate-to-severe dementia of the Alzheimer's type in the US.
    Saint-Laurent Thibault C; Özer Stillman I; Chen S; Getsios D; Proskorovsky I; Hernandez L; Dixit S
    J Med Econ; 2015; 18(11):930-43. PubMed ID: 26086535
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The use of acetyl cholinesterase inhibitors and memantine in nursing home residents.
    Gorus E; Van Puyvelde K; Corremans V; Mets T
    Acta Clin Belg; 2011; 66(5):361-6. PubMed ID: 22145270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term effects of the concomitant use of memantine with cholinesterase inhibition in Alzheimer disease.
    Lopez OL; Becker JT; Wahed AS; Saxton J; Sweet RA; Wolk DA; Klunk W; Dekosky ST
    J Neurol Neurosurg Psychiatry; 2009 Jun; 80(6):600-7. PubMed ID: 19204022
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk for Health Events After Deprescribing Acetylcholinesterase Inhibitors in Nursing Home Residents With Severe Dementia.
    Niznik JD; Zhao X; He M; Aspinall SL; Hanlon JT; Hanson LC; Nace D; Thorpe JM; Thorpe CT
    J Am Geriatr Soc; 2020 Apr; 68(4):699-707. PubMed ID: 31769507
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tacrine therapy is associated with reduced mortality in nursing home residents with dementia.
    Ott BR; Lapane KL
    J Am Geriatr Soc; 2002 Jan; 50(1):35-40. PubMed ID: 12028244
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is donepezil therapy associated with reduced mortality in nursing home residents with dementia?
    Gasper MC; Ott BR; Lapane KL
    Am J Geriatr Pharmacother; 2005 Mar; 3(1):1-7. PubMed ID: 16089241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of memantine in combination with acetylcholinesterase inhibitors on admission of patients with Alzheimer's disease to nursing homes: cost-effectiveness analysis in France.
    Touchon J; Lachaine J; Beauchemin C; Granghaud A; Rive B; Bineau S
    Eur J Health Econ; 2014 Nov; 15(8):791-800. PubMed ID: 23928827
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Underrecognition and undertreatment of dementia in Italian nursing homes.
    Cherubini A; Ruggiero C; Dell'Aquila G; Eusebi P; Gasperini B; Zengarini E; Cerenzia A; Zuliani G; Guaita A; Lattanzio F
    J Am Med Dir Assoc; 2012 Oct; 13(8):759.e7-13. PubMed ID: 22727993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sex Differences in Antipsychotic and Benzodiazepine Prescribing Patterns: A Cohort Study of Newly Admitted Nursing Home Residents with Dementia in Ontario, Canada.
    Maclagan LC; Maxwell CJ; Harris DA; Campitelli MA; Diong C; Lapane KL; Hogan DB; Rochon P; Herrmann N; Bronskill SE
    Drugs Aging; 2020 Nov; 37(11):817-827. PubMed ID: 32978758
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of anti-dementia drugs in home care and residential care and associations with neuropsychiatric symptoms: a cross-sectional study.
    Kuronen M; Koponen H; Nykänen I; Karppi P; Hartikainen S
    BMC Geriatr; 2015 Aug; 15():100. PubMed ID: 26268660
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acetylcholinesterase inhibitors combined with memantine for moderate to severe Alzheimer's disease: a meta-analysis.
    Glinz D; Gloy VL; Monsch AU; Kressig RW; Patel C; McCord KA; Ademi Z; Tomonaga Y; Schwenkglenks M; Bucher HC; Raatz H
    Swiss Med Wkly; 2019 Jun; 149():w20093. PubMed ID: 31269225
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors Associated with Mortality Including Nursing Home Transitions: A Retrospective Analysis of 25,418 People Prescribed Anti-Dementia Drugs in Northern Ireland.
    McMichael AJ; Zafeiridi E; Passmore P; Cunningham EL; McGuinness B
    J Alzheimers Dis; 2020; 73(3):1233-1242. PubMed ID: 31903992
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antidementia medication use by aged care facility residents with dementia.
    Lind KE; Gray LC; Raban MZ; Georgiou A; Westbrook JI
    Int J Geriatr Psychiatry; 2019 Jul; 34(7):1029-1040. PubMed ID: 30907450
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Geographic Variation of Antidementia and Antipsychotic Medication Use Among US Nursing Home Residents With Dementia.
    Rataj A; Alcusky M; Baek J; Ott B; Lapane KL
    Med Care; 2024 Aug; 62(8):511-520. PubMed ID: 38833712
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Withdrawal or continuation of cholinesterase inhibitors or memantine or both, in people with dementia.
    Parsons C; Lim WY; Loy C; McGuinness B; Passmore P; Ward SA; Hughes C
    Cochrane Database Syst Rev; 2021 Feb; 2(2):CD009081. PubMed ID: 35608903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trends in the Prescription and Long-Term Utilization of Antidementia Drugs Among Patients with Alzheimer's Disease in Spain: A Cohort Study Using the Registry of Dementias of Girona.
    Calvó-Perxas L; Turró-Garriga O; Vilalta-Franch J; Lozano-Gallego M; de Eugenio R; Márquez F; Carmona O; Gich J; Manzano A; Viñas M; Roig AM; Garre-Olmo J;
    Drugs Aging; 2017 Apr; 34(4):303-310. PubMed ID: 28258538
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.